These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20045321)

  • 1. An octahydro-cyclopenta[c]pyrrole series of inhibitors of the type 1 glycine transporter.
    Lowe JA; Deninno SL; Drozda SE; Schmidt CJ; Ward KM; David Tingley F; Sanner M; Tunucci D; Valentine J
    Bioorg Med Chem Lett; 2010 Feb; 20(3):907-11. PubMed ID: 20045321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and SAR studies of novel GlyT1 inhibitors.
    Walter MW; Hoffman BJ; Gordon K; Johnson K; Love P; Jones M; Man T; Phebus L; Reel JK; Rudyk HC; Shannon H; Svensson K; Yu H; Valli MJ; Porter WJ
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5233-8. PubMed ID: 17629697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter.
    Lowe JA; Hou X; Schmidt C; David Tingley F; McHardy S; Kalman M; Deninno S; Sanner M; Ward K; Lebel L; Tunucci D; Valentine J; Bronk BS; Schaeffer E
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2974-6. PubMed ID: 19410451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice.
    Kopec K; Flood DG; Gasior M; McKenna BA; Zuvich E; Schreiber J; Salvino JM; Durkin JT; Ator MA; Marino MJ
    Biochem Pharmacol; 2010 Nov; 80(9):1407-17. PubMed ID: 20637735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of GlyT1 inhibitors with improved pharmacokinetic properties.
    Wolkenberg SE; Zhao Z; Wisnoski DD; Leister WH; O'Brien J; Lemaire W; Williams DL; Jacobson MA; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Gibson C; Ma BK; Polsky-Fisher SL; Lindsley CW; Hartman GD
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1492-5. PubMed ID: 19181525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and structure-activity relationship of simple bis-amides as potent inhibitors of GlyT1.
    Jolidon S; Alberati D; Dowle A; Fischer H; Hainzl D; Narquizian R; Norcross R; Pinard E
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5533-6. PubMed ID: 18805008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of potent GlyT1 inhibitors: in vitro and in vivo profiles.
    Bridges TM; Williams R; Lindsley CW
    Curr Opin Mol Ther; 2008 Dec; 10(6):591-601. PubMed ID: 19051137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and in vivo efficacy of glycine transporter-1 (GlyT1) inhibitors derived from a series of [4-phenyl-1-(propylsulfonyl)piperidin-4-yl]methyl benzamides.
    Lindsley CW; Zhao Z; Leister WH; O'Brien J; Lemaire W; Williams DL; Chen TB; Chang RS; Burno M; Jacobson MA; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Tsou NN; Duggan ME; Conn PJ; Hartman GD
    ChemMedChem; 2006 Aug; 1(8):807-11. PubMed ID: 16902933
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors.
    Thomson JL; Blackaby WP; Jennings AS; Goodacre SC; Pike A; Thomas S; Brown TA; Smith A; Pillai G; Street LJ; Lewis RT
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2235-9. PubMed ID: 19318248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthesis and SAR of 2-arylsulfanylphenyl-1-oxyalkylamino acids as GlyT-1 inhibitors.
    Smith G; Mikkelsen G; Eskildsen J; Bundgaard C
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3981-4. PubMed ID: 16725323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycine-induced long-term synaptic potentiation is mediated by the glycine transporter GLYT1.
    Igartua I; Solís JM; Bustamante J
    Neuropharmacology; 2007 Jun; 52(8):1586-95. PubMed ID: 17462677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The scaffolding protein PSD-95 interacts with the glycine transporter GLYT1 and impairs its internalization.
    Cubelos B; González-González IM; Giménez C; Zafra F
    J Neurochem; 2005 Nov; 95(4):1047-58. PubMed ID: 16271045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides.
    Zhao Z; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Sur C; Pettibone DJ; Tiller PR; Smith S; Hartman GD; Wolkenberg SE; Lindsley CW
    Bioorg Med Chem Lett; 2006 Dec; 16(23):5968-72. PubMed ID: 16987662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors.
    Pinard E; Alberati D; Borroni E; Fischer H; Hainzl D; Jolidon S; Moreau JL; Narquizian R; Nettekoven M; Norcross RD; Stalder H; Thomas AW
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5134-9. PubMed ID: 18752953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate-based therapeutic approaches: inhibitors of glycine transport.
    Lechner SM
    Curr Opin Pharmacol; 2006 Feb; 6(1):75-81. PubMed ID: 16376148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 3-biphenyl-4-yl-4-phenyl-4H-1,2,4-triazoles as novel glycine transporter 1 inhibitors.
    Sugane T; Tobe T; Hamaguchi W; Shimada I; Maeno K; Miyata J; Suzuki T; Kimizuka T; Kohara A; Morita T; Doihara H; Saita K; Aota M; Furutani M; Shimada Y; Hamada N; Sakamoto S; Tsukamoto S
    J Med Chem; 2011 Jan; 54(1):387-91. PubMed ID: 21141920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycine transporter type-1 and its inhibitors.
    Harsing LG; Juranyi Z; Gacsalyi I; Tapolcsanyi P; Czompa A; Matyus P
    Curr Med Chem; 2006; 13(9):1017-44. PubMed ID: 16611082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of (4H-1,2,4-triazol-4-yl)isoquinoline derivatives as selective glycine transporter 1 inhibitors.
    Sugane T; Tobe T; Hamaguchi W; Shimada I; Maeno K; Miyata J; Suzuki T; Kimizuka T; Morita T; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2012 Jan; 20(1):34-41. PubMed ID: 22177408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional expression of the glycine transporter 1 on bullfrog retinal cones.
    Zhang XJ; Ge LH; Liu J; Yang XL
    Neuroreport; 2008 Nov; 19(17):1667-71. PubMed ID: 18841092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.